The University of Southampton
University of Southampton Institutional Repository

Vaccine based immunotherapy as a strategy to bypass drug resistance in multiple myeloma

Vaccine based immunotherapy as a strategy to bypass drug resistance in multiple myeloma
Vaccine based immunotherapy as a strategy to bypass drug resistance in multiple myeloma
Clonal evolution under therapy leads to drug resistance and relapse in multiple myeloma (MM), requiring new treatment mo- dalities to control disease. Immunotherapy and specifically vacci- nation to induce anti-tumor CD8+ cytotoxic T-cells (CTLs) provides one such strategy, but susceptibility of drug resistant MM cells to CTL attack is as yet not defined. To examine this, a first requirement is identification of tumour-associated antigens in drug refractory MM. To this end, we had previously specifically evaluated cancer testis antigens (CTAs) in MM for retention at relapse post- therapy, and identified SPAG9 and MAGEC1 as frontline antigen targets for vaccines. Of these, SPAG9 is generic to relapse MM (expressed in w100% of cases) and MAGEC1 is essentially tumour-specific (expressed w60% of cases). An optimal strategy for vaccination as therapy is in disease remission to attack re-emerging MM cells that escape drug therapy. A second requirement is to model drug resistance in MM, and accordingly we have now generated derivatives of the XG2 MM cell line that are resistant to melphalan (XG2 M) or Bortezomib (XG2 600R3); the RPMI8226-derivative R5 line with multiple drug resistance was also available. A third requirement is to show effective lysis of drug resistant MM cells by antigen specific CTLs. To generate antigen-specific CTLs, we utilized pDOM-CTAepitope DNA vaccine delivery in HLA-A2 transgenic HHD mice. We examined two epitopes in respective vaccines, pDOM-SPAG9p1 and pDOM-MAGEC1p2. Both vac- cines elicited epitope specific T-cell responses in HHD measured by IFN release assays following prime and boost with electroporation. Significantly, using MM cell lines made chimeric for HHD MHC class I as targets, both vaccines induced CTLs in HHD mice that were able to effectively lyse primary (XG2 and others) and drug resistant MM cell lines (XG2M, XG2 600R3, R5) effectively. These data demonstrate that drug resistant MM cells are susceptible to CTL killing, substantiating a role for vaccination in MM to over- come drug resistance and hence prevent relapse.
2152-2650
e285-e286
Wang, Chuan
f293763a-7eba-4d8e-a496-3b5e25a1a171
Gourzones, Claire
d1290f4c-e289-457f-b878-dc4a38f4462d
Weston-Bell, Nicola
c99c8c28-519f-4c3e-bd8c-679995a0472e
Rice, Jason
d58d4fcd-8dc0-4599-bf96-62323d579227
Zojer, Niklas
88a51a4d-0b56-4832-bc0f-f102fc49d656
Vacca, Angelo
0d7f030b-122f-4136-94a9-b6af484f8da8
Savelyeva, Natalia
804c3e15-d260-4717-9b7c-15c16ba87fc7
Sahota, Surinder
66c1457f-cba2-4c49-9c8c-fcee0748b6b8
Wang, Chuan
f293763a-7eba-4d8e-a496-3b5e25a1a171
Gourzones, Claire
d1290f4c-e289-457f-b878-dc4a38f4462d
Weston-Bell, Nicola
c99c8c28-519f-4c3e-bd8c-679995a0472e
Rice, Jason
d58d4fcd-8dc0-4599-bf96-62323d579227
Zojer, Niklas
88a51a4d-0b56-4832-bc0f-f102fc49d656
Vacca, Angelo
0d7f030b-122f-4136-94a9-b6af484f8da8
Savelyeva, Natalia
804c3e15-d260-4717-9b7c-15c16ba87fc7
Sahota, Surinder
66c1457f-cba2-4c49-9c8c-fcee0748b6b8

Wang, Chuan, Gourzones, Claire, Weston-Bell, Nicola, Rice, Jason, Zojer, Niklas, Vacca, Angelo, Savelyeva, Natalia and Sahota, Surinder (2015) Vaccine based immunotherapy as a strategy to bypass drug resistance in multiple myeloma. Clinical Lymphoma, Myeloma & Leukemia, 15 (Supplement 3), e285-e286. (doi:10.1016/j.clml.2015.07.586).

Record type: Meeting abstract

Abstract

Clonal evolution under therapy leads to drug resistance and relapse in multiple myeloma (MM), requiring new treatment mo- dalities to control disease. Immunotherapy and specifically vacci- nation to induce anti-tumor CD8+ cytotoxic T-cells (CTLs) provides one such strategy, but susceptibility of drug resistant MM cells to CTL attack is as yet not defined. To examine this, a first requirement is identification of tumour-associated antigens in drug refractory MM. To this end, we had previously specifically evaluated cancer testis antigens (CTAs) in MM for retention at relapse post- therapy, and identified SPAG9 and MAGEC1 as frontline antigen targets for vaccines. Of these, SPAG9 is generic to relapse MM (expressed in w100% of cases) and MAGEC1 is essentially tumour-specific (expressed w60% of cases). An optimal strategy for vaccination as therapy is in disease remission to attack re-emerging MM cells that escape drug therapy. A second requirement is to model drug resistance in MM, and accordingly we have now generated derivatives of the XG2 MM cell line that are resistant to melphalan (XG2 M) or Bortezomib (XG2 600R3); the RPMI8226-derivative R5 line with multiple drug resistance was also available. A third requirement is to show effective lysis of drug resistant MM cells by antigen specific CTLs. To generate antigen-specific CTLs, we utilized pDOM-CTAepitope DNA vaccine delivery in HLA-A2 transgenic HHD mice. We examined two epitopes in respective vaccines, pDOM-SPAG9p1 and pDOM-MAGEC1p2. Both vac- cines elicited epitope specific T-cell responses in HHD measured by IFN release assays following prime and boost with electroporation. Significantly, using MM cell lines made chimeric for HHD MHC class I as targets, both vaccines induced CTLs in HHD mice that were able to effectively lyse primary (XG2 and others) and drug resistant MM cell lines (XG2M, XG2 600R3, R5) effectively. These data demonstrate that drug resistant MM cells are susceptible to CTL killing, substantiating a role for vaccination in MM to over- come drug resistance and hence prevent relapse.

This record has no associated files available for download.

More information

e-pub ahead of print date: 27 September 2015
Published date: September 2015

Identifiers

Local EPrints ID: 417882
URI: http://eprints.soton.ac.uk/id/eprint/417882
ISSN: 2152-2650
PURE UUID: e344dd2c-5046-4ec3-97be-da0d9e6a2820
ORCID for Nicola Weston-Bell: ORCID iD orcid.org/0000-0003-0075-7276

Catalogue record

Date deposited: 16 Feb 2018 17:30
Last modified: 15 Mar 2024 18:29

Export record

Altmetrics

Contributors

Author: Chuan Wang
Author: Claire Gourzones
Author: Nicola Weston-Bell ORCID iD
Author: Jason Rice
Author: Niklas Zojer
Author: Angelo Vacca
Author: Surinder Sahota

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×